Lab-grown diamonds created through advanced technological processes have gained
popularity among consumers and have substantially impacted the pricing dynamics
of natural diamonds. The forthcoming decline in revenue
across the natural diamond industry is poised to be far-reaching and will
notably affect the unbranded, business-to-business (B2B) diamond markets.
This
decline primarily stems from the intensifying competition posed by synthetic
diamonds. Unlike economic fluctuations, which are transient, the shift of
consumer preference toward synthetic diamonds is enduring and stable.
Moreover,
the decreasing prices of lab-grown diamonds have reached a level where, even
with higher profit margins, their sales revenue may need to prove adequate for
conventional jewelers. This impending change underscores a significant and
sustained transformation in the diamond market landscape, driven by the
increasing prominence of lab-grown alternatives.
Approximately
five years ago, lab-grown gems were available at a 20% lower price compared to
natural diamonds. However, this discount has surged to nearly 80% today as
retailers continue to offer them at increasingly lower prices, driven by the
decreasing production costs. This year alone, the wholesale prices of lab diamonds have plummeted by over half.